| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 339.38M | — |
| Operating expense | — | — |
| Net income | 33.01M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, HAE returned +93.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +35.7% |
| 1 year | +93.0% |
| 5 years | +73.4% |
| 10 years | +192.8% |
| All-time high | $133.53 (Aug 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in HAE would be worth today ›No. Haemonetics Corporation has not paid a dividend in the past 12 months.
Haemonetics Corporation stock trades on NYSE under the ticker symbol HAE.
Haemonetics Corporation is part of the Healthcare sector.
Haemonetics Corporation has a market cap of 4.95B USD, based on the latest quote.
Haemonetics Corporation is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
